WILEX AG

 

 

ENGLISH DEUTSCH

Focused on oncology, WILEX develops diagnostic and therapeutic product candidates based on antibodies, which are available for out-licensing. The subsidiary Heidelberg Pharma GmbH offers preclinical contract research services and an antibody drug conjugate (ADC) technology platform.

 

Latest News

14.04.2015: WILEX publishes 3-month Financial Report. ....More

09.04.2015: WILEX subsidiary Heidelberg Pharma to present at two upcoming scientific conferences....More

 

Seite gelesen: 286862 | Heute: 242